SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Augmedix, Inc. (AUGX) .
本页证实的标准:
- VALUE (60/100, 通过) — 分析师目标价暗示上行空间 (+13.9%).
- 分析师共识目标价 $2.67 (+13.9% 上行空间) — 预期温和上涨。
SharesGrow 综合评分： 40/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
60/100
Price-to-Earnings & upside
Proven by this page
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — AUGX
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率2.30
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.44
每股账面价值$0.00
每股营收$1.02
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$2.67 (+13.9%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2018 |
$-20.32 |
$10.82M |
$-24.16M |
-223.4% |
| 2019 |
$-26.89 |
$14.11M |
$-22.36M |
-158.5% |
| 2020 |
$-2.10 |
$16.48M |
$-14.74M |
-89.4% |
| 2021 |
$-0.59 |
$22.17M |
$-17.16M |
-77.4% |
| 2022 |
$-0.71 |
$30.93M |
$-26.53M |
-85.8% |
| 2023 |
$-0.44 |
$44.86M |
$-19.17M |
-42.7% |
